These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 9203066)

  • 1. Treatment of children with Williams syndrome with methylphenidate.
    Bawden HN; MacDonald GW; Shea S
    J Child Neurol; 1997 Jun; 12(4):248-52. PubMed ID: 9203066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brief report: response to methylphenidate in two children with Williams syndrome.
    Power TJ; Blum NJ; Jones SM; Kaplan PE
    J Autism Dev Disord; 1997 Feb; 27(1):79-87. PubMed ID: 9018583
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of methylphenidate on preschool children with ADHD: cognitive and behavioral functions.
    Musten LM; Firestone P; Pisterman S; Bennett S; Mercer J
    J Am Acad Child Adolesc Psychiatry; 1997 Oct; 36(10):1407-15. PubMed ID: 9334554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Caregiver survey of pharmacotherapy to treat attention deficit/hyperactivity disorder in individuals with Williams syndrome.
    Martens MA; Seyfer DL; Andridge RR; Foster JE; McClure KE; Coury DL
    Res Dev Disabil; 2013 May; 34(5):1700-9. PubMed ID: 23500164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of OROS methylphenidate on academic, behavioral, and cognitive tasks in children 9 to 12 years of age with attention-deficit/hyperactivity disorder.
    Murray DW; Childress A; Giblin J; Williamson D; Armstrong R; Starr HL
    Clin Pediatr (Phila); 2011 Apr; 50(4):308-20. PubMed ID: 21436147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel multidomain computerized cognitive assessment for attention-deficit hyperactivity disorder: evidence for widespread and circumscribed cognitive deficits.
    Leitner Y; Doniger GM; Barak R; Simon ES; Hausdorff JM
    J Child Neurol; 2007 Mar; 22(3):264-76. PubMed ID: 17621495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of methylphenidate on attentional functions in children with attention-deficit/hyperactivity disorder.
    Konrad K; Gunther T; Hanisch C; Herpertz-Dahlmann B
    J Am Acad Child Adolesc Psychiatry; 2004 Feb; 43(2):191-8. PubMed ID: 14726726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurocognitive performance and behavioral symptoms in patients with attention-deficit/hyperactivity disorder during twenty-four months of treatment with methylphenidate.
    Wang LJ; Chen CK; Huang YS
    J Child Adolesc Psychopharmacol; 2015 Apr; 25(3):246-53. PubMed ID: 25574708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of methylphenidate on impulsive responding in children with attention-deficit hyperactivity disorder.
    Malone MA; Swanson JM
    J Child Neurol; 1993 Apr; 8(2):157-63. PubMed ID: 8505479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Buspirone versus methylphenidate in the treatment of children with attention- deficit/ hyperactivity disorder: randomized double-blind study.
    Mohammadi MR; Hafezi P; Galeiha A; Hajiaghaee R; Akhondzadeh S
    Acta Med Iran; 2012; 50(11):723-8. PubMed ID: 23292622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of methylphenidate on the cognitive and personality functioning of ADHD children.
    Lufi D; Parish-Plass J; Gai E
    Isr J Psychiatry Relat Sci; 1997; 34(3):200-9. PubMed ID: 9334525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short-term side effects of stimulant medication are increased in preschool children with attention-deficit/hyperactivity disorder: a double-blind placebo-controlled study.
    Firestone P; Musten LM; Pisterman S; Mercer J; Bennett S
    J Child Adolesc Psychopharmacol; 1998; 8(1):13-25. PubMed ID: 9639076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An Open-Label, Randomized Trial of Methylphenidate and Atomoxetine Treatment in Children with Attention-Deficit/Hyperactivity Disorder.
    Shang CY; Pan YL; Lin HY; Huang LW; Gau SS
    J Child Adolesc Psychopharmacol; 2015 Sep; 25(7):566-73. PubMed ID: 26222447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of comorbid autism spectrum disorders on stimulant response in children with attention deficit hyperactivity disorder: a retrospective and prospective effectiveness study.
    Santosh PJ; Baird G; Pityaratstian N; Tavare E; Gringras P
    Child Care Health Dev; 2006 Sep; 32(5):575-83. PubMed ID: 16919137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Executive impairment determines ADHD medication response: implications for academic achievement.
    Hale JB; Reddy LA; Semrud-Clikeman M; Hain LA; Whitaker J; Morley J; Lawrence K; Smith A; Jones N
    J Learn Disabil; 2011; 44(2):196-212. PubMed ID: 21383110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The effects of psychostimulants on the cognitive results and behaviour of children with the combined subtype of attention deficit with hyperactivity].
    Mulas F; Roselló B; Morant A; Hernández S; Pitarch I
    Rev Neurol; 2002 Jul 1-15; 35(1):17-24. PubMed ID: 12389187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of methylphenidate on subtypes of attention-deficit/hyperactivity disorder.
    Gorman EB; Klorman R; Thatcher JE; Borgstedt AD
    J Am Acad Child Adolesc Psychiatry; 2006 Jul; 45(7):808-16. PubMed ID: 16832317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenotypic psychiatric characterization of children with Williams syndrome and response of those with ADHD to methylphenidate treatment.
    Green T; Avda S; Dotan I; Zarchi O; Basel-Vanagaite L; Zalsman G; Weizman A; Gothelf D
    Am J Med Genet B Neuropsychiatr Genet; 2012 Jan; 159B(1):13-20. PubMed ID: 22052570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of methylphenidate on cognition and behaviour in children with neurofibromatosis type 1: a study protocol for a randomised placebo-controlled crossover trial.
    Pride NA; Barton B; Hutchins P; Coghill DR; Korgaonkar MS; Hearps SJC; Rouel M; Malarbi S; North KN; Payne JM
    BMJ Open; 2018 Aug; 8(8):e021800. PubMed ID: 30166301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and tolerability of OROS methylphenidate in Korean children with attention-deficit/hyperactivity disorder.
    Lee SI; Hong SD; Kim SY; Kim EJ; Kim JH; Kim JH; Park MK; Park S; Park JH; Oh EY; Lim TS; Cheong S; Cho IH; Choi JW
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):210-6. PubMed ID: 17046131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.